The ptdiatrician faced with advising on infant feeding is in a dilemma. On the one hand there are substantial reasons for avoiding under-feeding of infants in the first few days of life but it appears that the uncritical giving of large quantities of modified cow's milk may fail to achieve this aim and at the same time expose the infants to yet another iatrogenic disease. Dr Nina A J Carson (Department ofChild Health, Queen's University ofBelfast and the Royal Belfast Hospital for Sick Children)
Homocystinuria
Homocystinuria is an inborn error in the metabolism of the essential sulphur-containing amino acid, methionine. The disorder was first described in 1962 by Carson & Neill in Northern Ireland and Gerritsen et al. in America. The main metabolic pathway of methionine is through homocysteine and cystathionine to cysteine. In homocystinuria there is a metabolic block between homocysteine and cystathionine (Fig 1) due to a deficiency or abnormality of the specific enzyme cystathionine synthetase. As a result, homocysteine accumulates in the blood and tissues, and as it is a 'non-threshold' amino acid is rapidly excreted in the urine in its oxidized form, homocystine. The back reaction to methionine favoured by the homocysteine accumulation results in high blood concentrations of methionine and an increased urinary excretion when its tubular reabsorptive capacity is exceeded. As cysteine cannot be formed, this now becomes an essential amino acid. Because homocysteine and cysteine are rapidly oxidized both enzymatically and non-enzymatically, these compounds have been estimated in their more stable oxidized form of homocystine and cystine.
Clinical Features
Patients present a distinctive clinical picture. The majority have fair hair, a malar flush, poor peripheral circulation with well marked livido reticularis. Nearly all develop ectopia lentis and are mentally retarded. This appears to be a progressive disease. Overt clinical signs of the condition are not present at birth and affected infants develop normally during the first one to two years of life. Developmental retardation is often the first clinical sign. Later, involvement of the eyes and of the cardiovascular, musculoskeletal and haemopoietic sysfems becomes evident, also hepatic dysfunction and further extension of the neurological damage.
Eye defects: Of 20 patients known in Northern Ireland, 18 have ectopia lentis. The remaining two patients are now 4 months, and 2 years 7 months old respectively; both are under treatment. In this series, the youngest child found to have dislocated lenses was 22 months at the time of examination. Another patient is of interest in that when examined by an ophthalmologist at age 4 years severe myopia was noted, but ectopia lentis was not apparent until 3 years later. Severe myopia, pupil-block glaucoma and retinal detachment can occur as additional complications. Acute pupil-block glaucoma developed in twelve of the 20 patients; the management of this complication has been described by Johnston (1968) . These individuals are inclined to misjudge distance in depth by reason of the dislocation of the lens and associated astigmatism and myopia.
Cardiovascular system: The cardiovascular abnormalities take the form of fibrous intimal changes in the heart and blood vessels of all sizes. In the aorta and its branches and medium-sized muscular arteries there is also fragmentation and (Gibson et al. 1964) . Clinically, cardiac murmurs, cardiomegaly and hypertension have been noted in some patients.
Musculoskeletal system: Skeletal defects occur in all patients except young infants and vary from pes cavus and genu valgum in the younger children, to a typical Marfan-like picture in later childhood. Cases seen for the first time in adolescence may thus be mistaken for the Marfan syndrome. Whereas hypermobility of joints is a feature of the latter condition, by contrast patients with homocystinuria tend to complain of stiffness of the hands and occasionally the shoulders, though on clinical examination it is not possible to demonstrate limitation of movement. An additional useful distinguishing feature is the finding on radiological examination of osteoporotic changes in homocystinuria. Myopathic features have been demonstrated by electromyography studies in seven out of nine patients examined, and in five obvious pelvic girdle weakness was present (Hurwitz et al. 1968) . Hw,mopoietic system: Although anemia is not a feature of homocystinuria, folic acid levels tend to be decreased or at the lower limits of normal; it has been shown by Carey, Donovan, Fitzgerald & McAuley (1968) that this may result from excessive utilization of folate in the form of methyltetrahydrofolate, which acts as a methyl donor in the transmethylation reaction from homocysteine to methionine. Despite the low folic acid levels recorded none of these patients had evidence of megaloblastic bone marrow reaction. Carey, Fennelly & Fitzgerald (1968) reported a decrease in plasma homocystine and a rise in plasma methionine in homocystinuric patients treated with folic acid.
One of the most serious consequences of the abnormal biochemistry is the tendency to thromboembolic episodes. As thrombi occurred in both arteries and veins, hypercoagulability of the blood has been suspected. Increased platelet adhesiveness was reported in five of the Northern Ireland patients by McDonald et al. (1964) who also found that homocystine added to normal blood, in similar concentration to that found in homocystinuria, reproduced the platelet stickiness. This work has not been substantiated by other workers. More recently it has been noted by Ratnoff (1968) that homocystine activates the Hageman factor which has the capacity to initiate clotting and he suggests that perhaps the strategically localized deposition of homocystine in the intima of blood vessels may be responsible for the unusual frequency of thrombosis in these patients. Whatever the cause, four and possibly six of our patients with homocystinuria have died as a result of thrombotic episodes.
Hepatic dysfunction: Hepatomegaly has been recorded in three patients. Liver tissue obtained by biopsy or at necropsy of 4 patients has shown centrilobular fatty degeneration; this has also been reported by other workers. Although routine liver function tests have shown no significant abnormality, elevation of serum enzymes glutamic oxalacetic transaminase, glutamic pyruvate transaminase, isocitric dehydrogenase, leucine aminopeptidase and lactic dehydrogenase has been recorded in some patients.
Neurological findings: As already stated, mental retardation is slowly progressive; other neurological signs include fitsthese occurred in seven of our patients, three of whom had electroencephalograms performed which showed a generalized abnormality. Many of the patients have been observed to have a peculiar gait which tends to be stiff legged, sometimes high stepping, sometimes shuffling, often wide-based in character, and probably the result of a combination of neurological and myopathic involvement, possibly augmented by the visual disturbance. Increased nervousness and excitability are a feature of some patients. A high incidence of schizophrenia has been noted in some families (Carson et al. 1963 , Carey, Donovan, Fitzgerald & McAuley 1968 , Dunn et al. 1966 ) and one patient has been described who was being treated for schizophrenia before the diagnosis of homocystinuria was made (Spiro et al. 1965 ).
Diagnosis
The biochemical diagnosis is established by finding increased quantities of homocystine and methionine in the blood and homocystine in the urine. The diagnosis is suggested by finding a positive nitroprusside/cyanide test in the urine. As a positive reaction may be due to excess cystine or homocystine an ion exchange chromatographic technique is obligatory for final identification.
Genetics
Data of family studies so far reported are compatible with an autosomal recessive type of inheritance. As in most other disorders of amino acid metabolism there is no easy way of detecting heterozygotes. The results of methionine loading tests have been disappointing. Quantitative estimation of hepatic cystathionine synthetasecan be performed but is not a practical procedure. Recent work on fibroblast cultures from skin biopsies has yielded promising results with absence or very low levels of the specific enzyme in patients with homocystinuria compared to, healthy controls (Uhlendorf & Mudd 1968) . More meaningful and helpful genetic counselling would clearly be possible if reliable practical tests could be established for the detection of heterozygotes. This could possibly be carried a step further if foetal fibroblasts could be cultured from amniotic fluid at an early stage in pregnancy and the presence or absence of cystathionine synthetase established in those foetuses at risk. Termination of pregnancy in the case of an affected feetus could then be considered.
Treatment
As with other inborn errors of amino acid metabolism, treatment is by environmental manipulation. A diet low in methionine with added cystine has been used with success in infants, but because of the monotony of the diet it is difficult to keep older children and adults on it for any length of time. A balanced amino acid mixture low in nmethionine with added cystine suitable for infants is now available1unfortunately, as this is a protein hydrolysate the taste is objectionable. Another approach to therapy is supplementation with coenzymes. As pyridoxine is the coenzyme necessary to activate the apoenzyme cystathionine synthetase, excess oral supplements of this vitamin have been used in an attempt to activate the abnormal enzyme in these patients. This has met with varying biochemical success; in some instances the homocystine has disappeared from the blood and methionine levels have reverted to normal, while in others the abnormal chemistry has remained unaltered (Barber & Spaeth 1967 , Hooft et al. 1967 , Turner 1967 , Perry et al. 1968 , Cusworth & Dent 1969 . From a study of 12 patients in Northern Ireland (aged 4 days to 29 years) treated with excess oral pyridoxine (150-600 mg daily) it has become apparent that, though clinically indistinguishable, patients can be divided into two 'biochemical' groups, those who are resistant and those who are responsive to pyridoxine (Carson & Carre 1969) . The twelve patients studied were from seven families, and all affected members in any one family reacted in like manner to pyridoxine. These observations would suggest that there are two different basic defects in the enzyme cystathionine synthetase. In those who are biochemically resistant to B6 the basic defect is probably a deficiency of the apoenzyme cystathionine synthetase, as described by Mudd et al. (1964) . Those who are sensitive to B6 would appear to constitute yet another example of a pyridoxine-dependent syndrome. As there is no evidence of pyridoxine deficiency in these latter 'Scientific Hospital Supplies, 38 Queensland Street, Liverpool 7 patients we can only postulate at this stage of our knowledge that they have a structurally abnormal apoenzyme which requires excess B6 for its activation. These patients do not seem to suffer any apparent harmful effects from the continuous high doses of B6. In the Northern Ireland group, the longest period of treatment in the responsive patients has been 2 years 3 months. The only untoward finding has been a lowering of folic acid levels in 5 patients. Bone marrow examination was performed in 3 of these but only one showed a megaloblastic reaction and anmmia.
As mentioned above, folic acid can be used therapeutically since it is known that its administration lowers the homocystine blood level and causes an elevation in the plasma methionine. If this latter amino acid is already markedly increased this mode of therapy might be considered undesirable.
Irrespective of the form of therapy used to correct the abnormal biochemistry, too few patients have been studied for too short a period for any conclusions to be drawn as to their value in preventing the sequelh of this disorder. This is only one of many unsolved aspects of homocystinuriafor example the reasons underlying the clotting diathesis, the connective tissue abnormality and the cause of the cerebral defect have yet to be elucidated.
